Physician profile
Gregory Margolin
NPI 1699908400
$1,239.10
in general payments reported to CMS, 2019-2025
22 companies · $337 in 2025
The $337 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $357 · 2020: $115 · 2021: $34.88 · 2023: $110 · 2024: $286 · 2025: $337.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $648 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $647.53 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $338.29 | 2023-2025 | Veozah |
| Gynesonics, INC. | $148.86 | 2019-2025 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Exact Sciences Corporation | $118.66 | 2024-2025 | Cologuard Collection Kit |
| Bayer Healthcare Pharmaceuticals INC. | $99.93 | 2019-2025 | |
| Abbvie INC. | $65.56 | 2019-2021 | |
| Ethicon US, LLC | $59.40 | 2019-2020 | |
| Millicent US INC | $44.81 | 2019-2025 | Intrarosa, Femlyv |
| Exeltis, USA INC. | $39.24 | 2021-2024 | Slynd |
| Coopersurgical, INC. | $35.51 | 2025 | Paragard T 380a |
| Hologic Sales and Service, LLC | $32.15 | 2019-2025 | Aptima |
| Amgen INC. | $29.26 | 2019 | |
| Sumitomo Pharma America, INC. | $28.73 | 2024-2025 | Myfembree |
| Therapeuticsmd, INC. | $28.61 | 2019-2020 | |
| Lupin INC. | $27.29 | 2019-2020 | |
| Daiichi Sankyo INC. | $26.95 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avion Pharmaceuticals | $25.54 | 2019-2020 | |
| Pfizer INC. | $18.20 | 2024 | |
| Mayne Pharma Commercial LLC | $17.60 | 2024 | |
| Merck Sharp & Dohme LLC | $15.59 | 2024 | Gardasil, Gardasil 9 |
| Sage Therapeutics, LLC | $15.31 | 2025 | Zurzuvae |
| Amag Pharmaceuticals, INC. | $12.18 | 2020 | |
| Covidien LP | $11.43 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Margolin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.